The generation of FXN antisense transcript 1 (FAST-1) has been associated with gene silencing mechanisms in FRDA patients, as evidence suggests that FAST-1 is not detected in unaffected individuals (Hahn et al., 2010). The gene discussed is FOXH1; the disease is Friedreich ataxia.